(Reuters) – The head of the European Union's Medicines Agency said on Thursday that the agency's work on assessing COVID-19 vaccines had not been disrupted by a cyber attack that had taken place in the past two weeks.
U.S. Pharmaceutical manufacturer Pfizer and its German partner BioNTech said on Wednesday that documents related to the development of their COVID-19 vaccine had been "illegally displayed" in a cyber-attack against the European Medicines Agency (EMA).
The EMA had revealed the attack hours earlier. but gave no details about when or how it took place, who was responsible or what information was compromised.
"We have been the target of a cyberattack in recent weeks," Emer Cooke told EU lawmakers during a hearing on Thursday. . "I can assure you that this will not affect the timeline for vaccine delivery and that we are fully functional."
Pfizer and BioNTech said they did not believe that personal data about the trial participants had been compromised and EMA "has assured us that the cyberattack will have no effect on the timeline for its review.
The Agency has stated that it will decide on the possible conditional approval of the Pfizer-BioNTech COVID-1
Hacking attempts against health care organizations have intensified during the COVID-19 pandemic as attackers range from state-sponsored spies to cybercriminals.
More insurance and risk management news about the coronavirus crisis here.